Wen Tian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wen Tian has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
Ping Wang
Department of Thyroid Surgery, The Second Affiliated Hospital of Zhejiang University, Hangzhou, 310003, Zhejiang Province, China
8 shared publicationsBing Wang
Senior Department of General Surgery, the First Medical Center of Chinese PLA General Hospital, Beijing, China
7 shared publicationsZheng Wan
Senior Department of General Surgery, the First Medical Center of Chinese PLA General Hospital, Beijing, China
6 shared publicationsJing Yao
Senior Department of General Surgery, the First Medical Center of Chinese PLA General Hospital, Beijing, China
5 shared publicationsYanbing Jian
5 shared publicationsXin Miao
Senior Department of General Surgery, the First Medical Center of Chinese PLA General Hospital, Beijing, China
4 shared publications
Latest Publications
- Open Access
- 8 August 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
PEG3 inhibits mitophagy of papillary thyroid carcinoma through ISG15/VCP axis
Interferon-stimulated gene 15 (ISG15) is an essential biomarker in several cancers. However, the molecular mechanism of ISG15 regulating thyroid carcinoma (THCA) has rarely been studied. In our study, papillary thyroid carcinoma cell lines of TPC-1 and IHH-4, clinical samples of THCA, and nude mice were employed. The expression levels of genes were tested by real-time quantitative PCR and western blotting analyses. Cell activity was assessed using cell counting kit-8 assay and colony formation assays. Flow cytometry measured the ROS level and mitochondrial membrane potential. To induce mitophagy, cells were treated with 10µM CCCP (Carbonyl Cyanide m-Chlorophenylhydrazone) for 6 h. The level of mitophagy was assessed by transmission electron microscopy, LC3B-TOMM20 co-localization, mitochondrial Parkin level, p-S65-Ub and related protein expression. Co-immunoprecipitation assays determined the binding relationship between ISG15 and VCP. Chromatin immunoprecipitation, electrophoretic mobility shift and dual-luciferase reporter assay measured the targeting of PEG3 on the ISG15 promoter. Our results showed that ISG15 was highly expressed in THCA. ISG15 overexpression promoted cell proliferation and mitophagy. Mechanistically, ISG15 bound to VCP and promoted its stability. VCP integrated with ISG15 to promote cell viability, and mitophagy. Further experiments revealed that PEG3, which acted as a transcriptional inhibitor of ISG15, exerted an effect opposing that of ISG15. The role of ISG15 and PEG3 were also confirmed in xenograft mice model. In conclusion, our present study explored the molecular mechanism of ISG15 on THCA and found that PEG3 transcriptionally regulated ISG15 and promoted the proliferation and mitophagy of papillary thyroid carcinoma cells through VCP. Our present study revealed a novel mechanism of ISG15 on THCA, which might be a promising therapeutic target for THCA.
- 8 August 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
Open AccessPEG3 inhibits mitophagy of papillary thyroid carcinoma through ISG15/VCP axis
Interferon-stimulated gene 15 (ISG15) is an essential biomarker in several cancers. However, the molecular mechanism of ISG15 regulating thyroid carcinoma (THCA) has rarely been studied. In our study, papillary thyroid carcinoma cell lines of TPC-1 and IHH-4, clinical samples of THCA, and nude mice were employed. The expression levels of genes were tested by real-time quantitative PCR and western blotting analyses. Cell activity was assessed using cell counting kit-8 assay and colony formation assays. Flow cytometry measured the ROS level and mitochondrial membrane potential. To induce mitophagy, cells were treated with 10µM CCCP (Carbonyl Cyanide m-Chlorophenylhydrazone) for 6 h. The level of mitophagy was assessed by transmission electron microscopy, LC3B-TOMM20 co-localization, mitochondrial Parkin level, p-S65-Ub and related protein expression. Co-immunoprecipitation assays determined the binding relationship between ISG15 and VCP. Chromatin immunoprecipitation, electrophoretic mobility shift and dual-luciferase reporter assay measured the targeting of PEG3 on the ISG15 promoter. Our results showed that ISG15 was highly expressed in THCA. ISG15 overexpression promoted cell proliferation and mitophagy. Mechanistically, ISG15 bound to VCP and promoted its stability. VCP integrated with ISG15 to promote cell viability, and mitophagy. Further experiments revealed that PEG3, which acted as a transcriptional inhibitor of ISG15, exerted an effect opposing that of ISG15. The role of ISG15 and PEG3 were also confirmed in xenograft mice model. In conclusion, our present study explored the molecular mechanism of ISG15 on THCA and found that PEG3 transcriptionally regulated ISG15 and promoted the proliferation and mitophagy of papillary thyroid carcinoma cells through VCP. Our present study revealed a novel mechanism of ISG15 on THCA, which might be a promising therapeutic target for THCA.
- Open Access
- 10 March 2026
- Published by Elsevier in Cell Reports Medicine
- Vol. 7 (3) , 102664
A targeted proteomics assay for the preoperative diagnosis of thyroid nodules
- 10 March 2026
- Published by Elsevier in Cell Reports Medicine
- Vol. 7 (3) , 102664
Open AccessA targeted proteomics assay for the preoperative diagnosis of thyroid nodules
- Open Access
- 20 November 2025
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 12, 1663126
Retrospective observational study between robotic thyroidectomy via bilateral axillo-breast approach and conventional open surgery for thyroid cancer
Background: Robotic thyroidectomy has shown good acceptance results and improved cosmetic outcomes. This study aimed to evaluate the safety and efficacy of bilateral axillary-breast approach (BABA) robotic thyroidectomy compared with conventional open surgery for the treatment of thyroid cancer. Methods: The clinicopathological features and surgical outcomes of 73 papillary thyroid cancer patients treated by robotic surgery using the BABA approach and 62 papillary thyroid cancer patients treated by open surgery in our department from January 2024 to January 2025 were analyzed and compared. Results: The operation time was longer in the robotic group than in the open surgery group ( P = 0.001). However, when thyroid cancer requires lymph node dissection in the lateral neck area, the open operation time is longer than that of robotic surgery, although it is no significant ( P > 0.05). The estimated blood loss was lower in the robotic group than in the open surgery group ( P < 0.001). Both total number of removed lymph nodes ( P = 0.019) and metastatic lymph nodes ( P = 0.002) were higher in the robotic group than in the open surgery group. Postoperative inflammatory reaction was higher in the robotic group than in the open surgery group ( P < 0.001). No significant difference was observed in the nerve injury or Chyle leakage between the two groups. No recurrence or metastasis was found. Conclusions: Compared with open surgery, BABA robot radical thyroid cancer surgery with lymph node dissection is safety and efficacy, and have advantages such as less intraoperative blood loss, no neck scar. Especially in lateral cervical lymph node dissection, robotic surgery has obvious advantages.
- 20 November 2025
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 12, 1663126
Open AccessRetrospective observational study between robotic thyroidectomy via bilateral axillo-breast approach and conventional open surgery for thyroid cancer
Background: Robotic thyroidectomy has shown good acceptance results and improved cosmetic outcomes. This study aimed to evaluate the safety and efficacy of bilateral axillary-breast approach (BABA) robotic thyroidectomy compared with conventional open surgery for the treatment of thyroid cancer. Methods: The clinicopathological features and surgical outcomes of 73 papillary thyroid cancer patients treated by robotic surgery using the BABA approach and 62 papillary thyroid cancer patients treated by open surgery in our department from January 2024 to January 2025 were analyzed and compared. Results: The operation time was longer in the robotic group than in the open surgery group ( P = 0.001). However, when thyroid cancer requires lymph node dissection in the lateral neck area, the open operation time is longer than that of robotic surgery, although it is no significant ( P > 0.05). The estimated blood loss was lower in the robotic group than in the open surgery group ( P < 0.001). Both total number of removed lymph nodes ( P = 0.019) and metastatic lymph nodes ( P = 0.002) were higher in the robotic group than in the open surgery group. Postoperative inflammatory reaction was higher in the robotic group than in the open surgery group ( P < 0.001). No significant difference was observed in the nerve injury or Chyle leakage between the two groups. No recurrence or metastasis was found. Conclusions: Compared with open surgery, BABA robot radical thyroid cancer surgery with lymph node dissection is safety and efficacy, and have advantages such as less intraoperative blood loss, no neck scar. Especially in lateral cervical lymph node dissection, robotic surgery has obvious advantages.
- Open Access
- 1 October 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (10) , 9644-9655
Diagnostic value of a dynamic artificial intelligence-based, ultrasound-assisted diagnostic system in differentiating between benign and malignant thyroid nodules with a diameter greater than 2 cm
Background: In the diagnosis of larger thyroid nodules, the internal structure of the nodules and the surrounding tissues are more complex, making the nodule characteristics atypical. The tissue structure may interfere with the ultrasound examination, increasing the risk of misdiagnosis or missed diagnosis. Meanwhile, the uneven distribution of malignant tissues in large nodules or the tendency of large nodules to undergo necrosis and liquefaction due to their size can lead to a higher false-negative rate in fine needle aspiration cytology (FNAC). This study aimed to evaluate the clinical utility of a dynamic artificial intelligence (AI)-based, ultrasound-assisted diagnostic system in differentiating between benign and malignant thyroid nodules with a diameter >2 cm, and its guiding significance for subsequent management. Methods: The surgical data of 276 patients with 297 thyroid nodules who underwent surgery were collected. Dynamic AI was used to distinguish between the benign and malignant thyroid nodules. The dynamic AI, preoperative ultrasound, preoperative FNAC, computed tomography (CT), and postoperative pathological results of the nodules were compared to evaluate the diagnostic efficacy of dynamic AI. Results: Dynamic AI achieved 86.2% accuracy, with a sensitivity of 86.2% and a specificity of 86.2%, and showed high consistency with the postoperative pathological results (kappa =0.723, P4.0 cm groups. Conclusions: With its non-invasive, safe, objective, and accurate advantages, dynamic AI can conduct real-time, multi-section, and multi-angle diagnosis. It can deeply analyze the subtle characteristics of large thyroid nodules and provide a more objective comprehensive assessment of thyroid nodules with a diameter >2 cm, enabling the precise diagnosis of the benignity or malignancy of these nodules. It promotes the homogenization of diagnosis and has important guiding significance for individualized diagnosis and treatment strategies, and the development of surgical resection ranges.
- 1 October 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (10) , 9644-9655
Open AccessDiagnostic value of a dynamic artificial intelligence-based, ultrasound-assisted diagnostic system in differentiating between benign and malignant thyroid nodules with a diameter greater than 2 cm
Background: In the diagnosis of larger thyroid nodules, the internal structure of the nodules and the surrounding tissues are more complex, making the nodule characteristics atypical. The tissue structure may interfere with the ultrasound examination, increasing the risk of misdiagnosis or missed diagnosis. Meanwhile, the uneven distribution of malignant tissues in large nodules or the tendency of large nodules to undergo necrosis and liquefaction due to their size can lead to a higher false-negative rate in fine needle aspiration cytology (FNAC). This study aimed to evaluate the clinical utility of a dynamic artificial intelligence (AI)-based, ultrasound-assisted diagnostic system in differentiating between benign and malignant thyroid nodules with a diameter >2 cm, and its guiding significance for subsequent management. Methods: The surgical data of 276 patients with 297 thyroid nodules who underwent surgery were collected. Dynamic AI was used to distinguish between the benign and malignant thyroid nodules. The dynamic AI, preoperative ultrasound, preoperative FNAC, computed tomography (CT), and postoperative pathological results of the nodules were compared to evaluate the diagnostic efficacy of dynamic AI. Results: Dynamic AI achieved 86.2% accuracy, with a sensitivity of 86.2% and a specificity of 86.2%, and showed high consistency with the postoperative pathological results (kappa =0.723, P4.0 cm groups. Conclusions: With its non-invasive, safe, objective, and accurate advantages, dynamic AI can conduct real-time, multi-section, and multi-angle diagnosis. It can deeply analyze the subtle characteristics of large thyroid nodules and provide a more objective comprehensive assessment of thyroid nodules with a diameter >2 cm, enabling the precise diagnosis of the benignity or malignancy of these nodules. It promotes the homogenization of diagnosis and has important guiding significance for individualized diagnosis and treatment strategies, and the development of surgical resection ranges.
- 18 July 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (9) , 6269
Correction: Chinese expert consensus on endoscopic and robotic parathyroid surgery (version 2025)
- 18 July 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (9) , 6269
Correction: Chinese expert consensus on endoscopic and robotic parathyroid surgery (version 2025)
- 14 July 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (9) , 5492-5505
Chinese expert consensus on endoscopic and robotic parathyroid surgery (version 2025)
Background With the increasingly widespread use of endoscopic and robotic surgery as intelligent and precise forms of minimally invasive surgery in parathyroid surgery, and in response to the lack of uniform guidelines for their clinical practice, this expert consensus has been formulated with the aim of promoting the standardized implementation and promotion of endoscopic and robotic parathyroid surgery. Methods Based on the latest literature and multicenter clinical experience, the expert group on thyroid surgery of the College of Surgeons of the Chinese Medical Association, the Thyroid Disease Specialty Committee of the Chinese Association of Research Hospitals and the Parathyroid and Bone Metabolism Disease Specialty Committee of the Chinese Association of Research Hospitals, the recommendations were formulated by a thorough discussion and multiple rounds of voting, and were ultimately developed This consensus (2025 edition). Results This consensus systematically describes the indications and contraindications for endoscopic and robotic parathyroid surgery (especially primary hyperparathyroidism PHPT, secondary SHPT, and tertiary THPT), preoperative evaluation and preparation (whole-body assessment, stereotactic approach, and equipment selection), surgical equipment and instruments, operator qualification and training, choice of surgical access (robotic: BABA, non-inflatable The key contents include axillary approach, transoral vestibular approach; endoscopic: neck, chest and breast, transoral, etc.), key points of surgical operation and perioperative management, and prevention and treatment of complications. At 14 (3) months post-revision, patients with abnormal DeMeester scores had higher rates of patient satisfaction (82.9 vs. 65.5%, p = 0.026) and freedom from PPIs (77.6 vs. 60.3%, p = 0.037) with lower GERD-HRQL total scores [7.0 (2.0–21.5) vs. 14.0 (6.0–32.0), p = 0.003]. Abnormal DeMeester score was the strongest predictor of favorable outcomes after revisional ARS [OR 3.98 (1.75–9.04), p = 0.001]. Conclusion The Chinese Expert Consensus on Endoscopic and Robotic Parathyroid Surgery (2025 Edition) provides comprehensive guidance and reference for clinicians to standardize, safely and effectively perform endoscopic and robotic parathyroid surgery.
- 14 July 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (9) , 5492-5505
Chinese expert consensus on endoscopic and robotic parathyroid surgery (version 2025)
Background With the increasingly widespread use of endoscopic and robotic surgery as intelligent and precise forms of minimally invasive surgery in parathyroid surgery, and in response to the lack of uniform guidelines for their clinical practice, this expert consensus has been formulated with the aim of promoting the standardized implementation and promotion of endoscopic and robotic parathyroid surgery. Methods Based on the latest literature and multicenter clinical experience, the expert group on thyroid surgery of the College of Surgeons of the Chinese Medical Association, the Thyroid Disease Specialty Committee of the Chinese Association of Research Hospitals and the Parathyroid and Bone Metabolism Disease Specialty Committee of the Chinese Association of Research Hospitals, the recommendations were formulated by a thorough discussion and multiple rounds of voting, and were ultimately developed This consensus (2025 edition). Results This consensus systematically describes the indications and contraindications for endoscopic and robotic parathyroid surgery (especially primary hyperparathyroidism PHPT, secondary SHPT, and tertiary THPT), preoperative evaluation and preparation (whole-body assessment, stereotactic approach, and equipment selection), surgical equipment and instruments, operator qualification and training, choice of surgical access (robotic: BABA, non-inflatable The key contents include axillary approach, transoral vestibular approach; endoscopic: neck, chest and breast, transoral, etc.), key points of surgical operation and perioperative management, and prevention and treatment of complications. At 14 (3) months post-revision, patients with abnormal DeMeester scores had higher rates of patient satisfaction (82.9 vs. 65.5%, p = 0.026) and freedom from PPIs (77.6 vs. 60.3%, p = 0.037) with lower GERD-HRQL total scores [7.0 (2.0–21.5) vs. 14.0 (6.0–32.0), p = 0.003]. Abnormal DeMeester score was the strongest predictor of favorable outcomes after revisional ARS [OR 3.98 (1.75–9.04), p = 0.001]. Conclusion The Chinese Expert Consensus on Endoscopic and Robotic Parathyroid Surgery (2025 Edition) provides comprehensive guidance and reference for clinicians to standardize, safely and effectively perform endoscopic and robotic parathyroid surgery.
- Open Access
- 1 June 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (6) , 3991-4004
Body mass index should be considered as an indicator for laparoscopic surgery or robot-assisted surgery selection in patients with hiatal hernia
Background: Hiatal hernia (HH), a prevalent clinical condition characterized by the protrusion of abdominal viscera into the thoracic cavity through the esophageal hiatus, remains a subject of ongoing debate regarding optimal surgical management strategies. This study aimed to analyze and compare the efficacy of robot-assisted versus laparoscopic repair of HH in patients with varying body mass index (BMI). Methods: We retrospectively analyzed the clinical data of patients with HH treated at the Chinese People’s Liberation Army (PLA) General Hospital from December 2013 to December 2023. A total of 142 patients were included and divided into three groups based on their BMI values: normal group (18.5 to 2), overweight group (24 to 2) and obese group (BMI ≥28.0 kg/m2). Preoperative baseline data, perioperative data and postoperative symptom improvement were analyzed to compare the benefits of the two surgical methods across different BMI groups. Results: In the normal group, compared to the laparoscopic group, the robot-assisted group exhibited less intraoperative bleeding, shorter postoperative time to first flatus, longer operation time, and more hospitalization costs (20.0 vs. 35.0 mL; 2.0 vs. 3.0 days; 113.00 vs. 100.00 min; ¥52,529 vs. ¥38,387), the differences were statistically significant (P0.05). In the overweight group, robot-assisted surgery was associated with significantly reduced intraoperative bleeding, shorter postoperative time to first flatus, shorter postoperative hospitalization time, lower postoperative pain scores, longer operation time and higher hospitalization costs (25.0 vs. 36.2 mL; 2.0 vs. 3.0 days; 4.0 vs. 5.0 days; 3.0 vs. 4.0 points; 115.00 vs. 104.00 min; ¥62,453 vs. ¥39,647), the difference was statistically significant (P0.05). In the obese group, compared with laparoscopic surgery, robot-assisted surgery manifested significantly reduced intraoperative bleeding (22.0 vs. 37.0 mL), faster postoperative flatus time (2.0 vs. 3.0 days), shorter hospitalization duration (4.0 vs. 5.0 days), lower postoperative pain scores (3.0 vs. 4.0 points), and marked improvement in reflux symptoms, despite higher total hospitalization costs (¥62,916 vs. ¥40,407). Operative time was comparable between the two groups, with no statistically significant difference (120.00 vs. 110.50 min, P>0.05). Conclusions: Under the financial burden of the higher costs associated with robot-assisted surgery, choosing robot-assisted surgery can provide more benefits for patients with a higher BMI, therefore, we recommend that BMI should be considered as an indicator when selecting surgical methods for patients.
- 1 June 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (6) , 3991-4004
Open AccessBody mass index should be considered as an indicator for laparoscopic surgery or robot-assisted surgery selection in patients with hiatal hernia
Background: Hiatal hernia (HH), a prevalent clinical condition characterized by the protrusion of abdominal viscera into the thoracic cavity through the esophageal hiatus, remains a subject of ongoing debate regarding optimal surgical management strategies. This study aimed to analyze and compare the efficacy of robot-assisted versus laparoscopic repair of HH in patients with varying body mass index (BMI). Methods: We retrospectively analyzed the clinical data of patients with HH treated at the Chinese People’s Liberation Army (PLA) General Hospital from December 2013 to December 2023. A total of 142 patients were included and divided into three groups based on their BMI values: normal group (18.5 to 2), overweight group (24 to 2) and obese group (BMI ≥28.0 kg/m2). Preoperative baseline data, perioperative data and postoperative symptom improvement were analyzed to compare the benefits of the two surgical methods across different BMI groups. Results: In the normal group, compared to the laparoscopic group, the robot-assisted group exhibited less intraoperative bleeding, shorter postoperative time to first flatus, longer operation time, and more hospitalization costs (20.0 vs. 35.0 mL; 2.0 vs. 3.0 days; 113.00 vs. 100.00 min; ¥52,529 vs. ¥38,387), the differences were statistically significant (P0.05). In the overweight group, robot-assisted surgery was associated with significantly reduced intraoperative bleeding, shorter postoperative time to first flatus, shorter postoperative hospitalization time, lower postoperative pain scores, longer operation time and higher hospitalization costs (25.0 vs. 36.2 mL; 2.0 vs. 3.0 days; 4.0 vs. 5.0 days; 3.0 vs. 4.0 points; 115.00 vs. 104.00 min; ¥62,453 vs. ¥39,647), the difference was statistically significant (P0.05). In the obese group, compared with laparoscopic surgery, robot-assisted surgery manifested significantly reduced intraoperative bleeding (22.0 vs. 37.0 mL), faster postoperative flatus time (2.0 vs. 3.0 days), shorter hospitalization duration (4.0 vs. 5.0 days), lower postoperative pain scores (3.0 vs. 4.0 points), and marked improvement in reflux symptoms, despite higher total hospitalization costs (¥62,916 vs. ¥40,407). Operative time was comparable between the two groups, with no statistically significant difference (120.00 vs. 110.50 min, P>0.05). Conclusions: Under the financial burden of the higher costs associated with robot-assisted surgery, choosing robot-assisted surgery can provide more benefits for patients with a higher BMI, therefore, we recommend that BMI should be considered as an indicator when selecting surgical methods for patients.
- Open Access
- 15 February 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1
Correction: Chinese expert consensus on transoral vestibular approach robotic thyroidectomy and parathyroidectomy (version 2024)
- 15 February 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1
Open AccessCorrection: Chinese expert consensus on transoral vestibular approach robotic thyroidectomy and parathyroidectomy (version 2024)
- Open Access
- 1 February 2025
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 21, 229-237
Chinese Expert Consensus on Preventing and Managing Chyle Fistula in Cervical Lymph Node Dissection for Thyroid Cancer (2024)
Background: The prevalence of thyroid carcinoma is on the rise, with cervical lymph node metastasis being a frequent occurrence necessitating surgical intervention. Chyle fistula, a significant postoperative complication, can have a substantial impact on recovery. Objective: To reduce the incidence of chyle fistula, enhance the effectiveness of postoperative treatment, and assist thyroid surgeons in performing cervical lymph node dissection, the consensus was compiled in a standardized and secure manner. Methods: Drawing from the expertise of Chinese specialists in managing chyle fistula and the latest international advancements in this field following cervical lymph node dissection, the thyroid tumor experts group of Chinese Thyroid Association, Chinese College of Surgeons, Chinese Medical Doctor Association and Thyroid Disease Professional Committee of Chinese Research Association have developed innovative approaches to address this issue. An evidence-based approach was employed, integrating the knowledge and practical experience of the panelists. Results: We developed twelve expert consensus recommendations, addressing the prevention, diagnosis, and treatment of postoperative chyle fistula. These recommendations included the dietary management and nutritional support, continuous negative pressure suction, local adhesive treatment, application of local compression methods, the use of somatostatin and its analogs, and surgery treatment. Conclusion: This evidence-based consensus would be valuable to assist front-line surgeons and medical specialists in the management of chyle fistula.
- 1 February 2025
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 21, 229-237
Open AccessChinese Expert Consensus on Preventing and Managing Chyle Fistula in Cervical Lymph Node Dissection for Thyroid Cancer (2024)
Background: The prevalence of thyroid carcinoma is on the rise, with cervical lymph node metastasis being a frequent occurrence necessitating surgical intervention. Chyle fistula, a significant postoperative complication, can have a substantial impact on recovery. Objective: To reduce the incidence of chyle fistula, enhance the effectiveness of postoperative treatment, and assist thyroid surgeons in performing cervical lymph node dissection, the consensus was compiled in a standardized and secure manner. Methods: Drawing from the expertise of Chinese specialists in managing chyle fistula and the latest international advancements in this field following cervical lymph node dissection, the thyroid tumor experts group of Chinese Thyroid Association, Chinese College of Surgeons, Chinese Medical Doctor Association and Thyroid Disease Professional Committee of Chinese Research Association have developed innovative approaches to address this issue. An evidence-based approach was employed, integrating the knowledge and practical experience of the panelists. Results: We developed twelve expert consensus recommendations, addressing the prevention, diagnosis, and treatment of postoperative chyle fistula. These recommendations included the dietary management and nutritional support, continuous negative pressure suction, local adhesive treatment, application of local compression methods, the use of somatostatin and its analogs, and surgery treatment. Conclusion: This evidence-based consensus would be valuable to assist front-line surgeons and medical specialists in the management of chyle fistula.
- 2 December 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-11
Chinese expert consensus on transoral vestibular approach robotic thyroidectomy and parathyroidectomy (version 2024)
The transoral robotic thyroidectomy (TORT) has been increasingly adopted for minimally invasive thyroid surgery and it has proved to have better cosmetic results and comparable surgical outcomes with open operations. Most reports on TORT are case series, or single center, small-sample controlled, retrospective studies, and clinical guidelines have not been established so far. To better promote the standardized implementation and widespread adoption of TORT in China, the expert panel have organized thyroid minimally invasive surgery experts and some robotic thyroidectomy experts in China jointly formulate the Chinese expert consensus on transoral vestibular approach robotic thyroidectomy and parathyroidectomy (2024 edition) based on the latest relevant literature and clinical experiences from multiple centers. This consensus aims to provide guidance and reference for colleagues.
- 2 December 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-11
Chinese expert consensus on transoral vestibular approach robotic thyroidectomy and parathyroidectomy (version 2024)
The transoral robotic thyroidectomy (TORT) has been increasingly adopted for minimally invasive thyroid surgery and it has proved to have better cosmetic results and comparable surgical outcomes with open operations. Most reports on TORT are case series, or single center, small-sample controlled, retrospective studies, and clinical guidelines have not been established so far. To better promote the standardized implementation and widespread adoption of TORT in China, the expert panel have organized thyroid minimally invasive surgery experts and some robotic thyroidectomy experts in China jointly formulate the Chinese expert consensus on transoral vestibular approach robotic thyroidectomy and parathyroidectomy (2024 edition) based on the latest relevant literature and clinical experiences from multiple centers. This consensus aims to provide guidance and reference for colleagues.